Kraig Labs R&D Team continues to deliver outstanding breakthroughs
ANN ARBOR, Mich., – June 4, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that, in recognition of the magnitude of multiple recent achievements, Dr. Trevor Kane has been promoted to the position of Chief Scientist.
His successes in creating new transgenics in the lab and expanding our intellectual property portfolio with several new provisional patent applications mark a significant milestone and advancement in Kraig Labs mission to produce and commercialize eco-friendly materials that exceed the performance and strength of native spider silk.
“These new powerful transgenics, recently created by Dr. Kane’s team, were designed for broad commercial appeal. Dr. Kane has certainly earned his promotion with the successful development of this new architecture. This next generation technology, developed in our labs, has the potential to radically advance gains in material performance, above and beyond anything we’ve previously produced,” said CEO and Founder, Kim Thompson.
“I would like congratulate and commend Dr. Kane and our entire R&D team for their success in developing these breakthrough technologies,” said COO Jon Rice.
These new transgenics incorporate several technologies covered by the Company’s recent provisional patent applications and set the stage for new commercial applications.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495